Cardiopulmonary Stress Testing Systems Market Expected to Reach USD 3.08 Billion in 2025: North America to be the most lucrative region by 2025

The Global Cardiopulmonary Stress Testing Systems Market was valued at US$ 2.08 Bn in 2016, expected to reach US$ 3.08 Bn by 2025, registering a CAGR of 4.6%, by value, during 2017-2025. The traditional exercise stress test studies blood pressure, heart rate, electrocardiography, oxygen saturation levels, and subjective symptom assessment is performed by physicians. Stress test with imaging, also known as myocardial perfusion scan, is performed in case of patients experiencing chest pain, and also for the assessment of heart performance and tolerability of patient which underwent heart attack or surgeries.

Read Report - https://www.transparencymarketresearch.com/cardiopulmonary-stress-testing-systems-market.html

Major players operating in the cardiopulmonary stress testing systems market space are focusing on technologically advanced devices with value added service assistance, whereas the startups and emerging new entrant are focused on developing affordable low value high volume products under the segments stress ECG, pulse oximeters, and stress blood pressure monitors.

The global cardiopulmonary stress testing systems market is classified on the basis of product type, end-user, and regions. Based on product type, the global cardiopulmonary stress testing systems market is categorized into cardiopulmonary exercise testing systems, pulse oximeters, stress electrocardiograph, stress blood pressure monitors, and single-photon emission computed tomography. In terms of end-user segment, the global cardiopulmonary stress testing systems market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and specialty clinics/cardiology clinics.

Inquire for a Sample Copy of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530

In 2016, the cardiopulmonary exercise testing systems segment dominated the global cardiopulmonary stress testing systems market in terms of value among the product type. The major reasons for the dominance of the cardiopulmonary exercise testing systems segment were the significant patient pool with cardiovascular diseases, high average selling prices of devices, innovations leading to portable cardiopulmonary exercise testing systems, among others. The cardiopulmonary exercise testing systems segment is likely to continue its dominance throughout the forecast period. Single-photon emission computed tomography segment is likely to lose the market share in terms of value in the global cardiopulmonary stress testing systems market during the forecast period owing to depletion of natural sources of radio isomers, high cost of myocardial perfusion studies, and declining patient preference due to incidences of cancer in some patients which underwent cardiac imaging studies.

Download a PDF Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1530

In terms of end-user, hospitals segment is projected to dominate the global cardiopulmonary stress testing systems market in terms of value during the forecast period. The growth of the segment is attributable to factors like rising patient as well as physician preference for early diagnosis of cardiovascular diseases, and extensive research on wireless and portable products. The diagnostic centers segment is likely grow at relatively higher CAGR in terms of value in the global cardiopulmonary stress testing systems market during the forecast period.

On the basis of geography, North America is projected to continue its dominance in the global cardiopulmonary stress testing systems market in terms of value during the forecast period, due to greater adoption of technologically advanced products and techniques, and high cost of cardiopulmonary exercise testing systems among all regions. Asia Pacific is anticipated to register relatively higher CAGR during the forecast period, in terms of value, owing to number of factors such as significant demand for better healthcare facilities, improving healthcare infrastructure, and increased adoption of traditional stress testing among the significant patient population.

Major players having presence in the global cardiopulmonary stress testing systems market include Koninklijke Philips N.V., Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.), General Electric Company (GE Healthcare), MGC Diagnostics Corporation, OSI Systems, Inc. (Spacelabs Healthcare), Masimo, NIHON KOHDEN CORPORATION, COSMED, Halma plc (SunTech Medical, Inc.), Schiller AG, and Vyaire Medical, Inc., among others.

Purchase this Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1530<ype=S

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.